A case of bilateral middle ear squamous cell carcinomas with concurrent Waldenström's macroglobulinemia is described. An increased incidence of malignant tumors occurring in patients with this potentially fatal, chronic lymphoproliferative disorder is well recognized, but the association with an otological tumor has not previously been reported. The relationship between the two conditions is discussed.
Get full access to this article
View all access options for this article.
References
1.
RobinsonGA. Malignant tumours of the ear. Laryngoscope1931; 41: 467–73.
2.
SchallLA. Neoplasms involving the middle ear. Arch Otolaryngol1935; 22: 548–53.
3.
PeeleJCHauserGH. Primary carcinoma of the external auditory canal and middle ear. Arch Otolaryngol1941; 34: 254–66.
4.
TowsonCEShoftstallWH. Carcinoma of the ear. Arch Otolaryngol1950; 51: 724–38.
5.
BradleyWHMaxwellJH. Neoplasms of the middle ear and mastoid. Report of 54 cases. Laryngoscope1954; 64: 533–56.
6.
LewisJS. Cancer of the ear. Laryngoscope1960; 70: 551–79.
7.
BolandJPatersonR. Cancer of the middle ear and external auditory meatus. J Laryngol Otol1955; 69: 468–78.
8.
LedermanM. Malignant tumours of the ear. J Laryngol Otol1965; 79: 85–119.
9.
TuckerWN. Cancer of the middle ear; a review of 89 cases. Cancer1965; 18: 642–50.
10.
FriedmannI. Pathology of the ear. Oxford: Blackwell Scientific Publications, 1974; 145–225.
11.
ConleyJSchullerDE. Malignancies of the ear. Laryngoscope1976; 86: 1147–63.
12.
JubyHB. Bilateral malignant disease of the middle ear. J Laryngol Otol1957; 71: 700–2.
13.
MichaelsLWellsM. Squamous cell carcinoma of the middle ear. Clin Otolaryngol1980; 5: 235–48.
14.
SchmidtPHVerdonkGJ. Bilateral carcinoma of the ear. J Laryngol Otol1967; 81: 567–9.
15.
HällénJ. Discrete gammaglobulin (M-) components in serum. Acta Med Scand1966; 179Suppl 462: 1.
16.
MacKenzieMRFudenbergHH. Macroglobulinaemia: An analysis of 40 patients. Blood1972; 39: 874–89.
17.
WaldenströmJ. Incipient myelomatosis or essential hyper-globinaemia with fibroinogenopenia: New syndrome?Acta Med Scand1944; 117: 216–47.
18.
BachmannR. The diagnostic significance of the serum concentration of pathological proteins (M-components). Acta Med Scand1965; 178: 801–8.
19.
HobbsJR. Paraproteins, benign or malignant?Br Med J1967; 3: 699–704.
FaheyJLScogginsRUtzJPSzwedCF. Infection antibody response in gammaglobulin components in multiple myeloma and macroglobulinaemia. Am J Med1963; 35: 698–705.
22.
SchaubF. Gleichzeitiges Vorkommen von Makroglobulinämie Waldenström und von malignen Tumoren. Schweiz Med Wchnschur1953; 83: 1256–7.
23.
KappelerRKrebsARivaG. Kliniker Makroglobulinämie Waldenström: Beschreibung von 21 fällen und ubersicht der literatur. Helv Med Acta (Basel)1958; 25: 54–101.
24.
RitzmannSELoukasDSakaiHDanielsJCLevinWC. Idiopathic (asymptomatic) monoclonal gammopathies. Ann Intern Med1975; 135: 95–106.
25.
OssermanEFTakatsukiK. Considerations regarding pathogenesis of the plasmacytic dyscrasias. Semin Hematol1964; 4: 28–52.
26.
SeligmannMDanonFMihaescoCFudenbergHH. Immunoglobulin abnormalities in families of patients with Waldenström's macroglobulinaemia. Am J Med1967; 43: 66–83.
27.
WilliamsRCEricksonJLPolsekyHFSwainWR. Studies of monoclonal immunoglobulins (M-components) in various kindreds. Ann Intern Med1967; 67: 309–27.
28.
KalffMWHijmansW. Immunoglobulin analysis in families of macroglobulinaemia patients. Clin Exp Immunol1969; 5: 479–98.
29.
AxelssonUBachmannRHällénJ. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand1966; 179: 235–47.
30.
ThomasL. Reactions to homologous tissue antigens. In: LawrenceHS, ed. Cellular and humoral aspects of the hypersensitive state. London: Cassell, 1959: 539.
31.
BurnetFM. Immunological surveillance in neoplasia. Transplant Rev1971; 7: 3–25.
32.
AllisonACTaylorRB. Observations on thymectomy and carcinogenesis. Cancer Res1967; 27: 703–7.
WagnerJLHaughtonG. Immune suppression by antilymphocytic serum and its effect on tumours induced by 3-methylcholanthane in mice. J Nat Cancer Inst1971; 46: 1–10.
35.
GattiRAGoodRA. Occurrence of malignancy in immunodeficiency diseases. Cancer1971; 28: 89–98.
36.
McKhannCF. Primary malignancy in patients undergoing immunosuppression for renal transplants. Transplantation1969; 8: 209–12.
37.
StarzlTEPennIPutnamCW. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev1971; 7: 112–45.
38.
WalderBKRobertsonMRJeremyD. Skin cancer and immunosuppression. Lancet1971; 2: 1282–3.
39.
PennI. Malignancies in recipients of organ transplants. John Hopkins Med J1974; Suppl 3: 211–21.
40.
LodgeWOJonesHMSmithMEN. Malignant tumours of the temporal bone. Arch Otolaryngol1955; 61: 535–41.
